ShorT and OPtimal Duration of Dual AntiPlatelet Therapy-2 Study

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2015
The purpose of this study is to evaluate the safety of reducing dual antiplatelet therapy (DAPT) duration to 1 month after implantation of the everolimus-eluting cobalt-chromium stent (CoCr-EES).
Epistemonikos ID: 3928ab16b8dcb52c850c2fd8e3bc794fb66ce9d2
First added on: May 12, 2024